Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro

被引:22
作者
Ramnarine, SI [1 ]
Khawaja, AM [1 ]
Barnes, PJ [1 ]
Rogers, DF [1 ]
机构
[1] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,NATL HEART & LUNG INST,LONDON SW3 6LY,ENGLAND
关键词
nitric oxide (NO); mucus secretion; N-G-monomethyl-L-arginine (L-NMMA); FK409;
D O I
10.1111/j.1476-5381.1996.tb15498.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 In order to examine the role of nitric oxide (NO) on airway mucus secretion we studied the effects of the nitric oxide synthase (NOS) inhibitor L-N-G-monomethyl-L-arginine (L-NMMA), a novel nitric oxide donor, (+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide (FK409), and the NO precursor L-arginine on basal mucus secretion in the ferret trachea in vitro in Ussing chambers. We also determined the effects of these agents upon secretion induced by electrical stimulation of nerves or by acetylcholine (ACh). We used (SO4)-S-35 as a mucus marker. 2 L-NMMA (0.01-1 mM) increased basal output of (SO4)-S-35-labelled macromolecules with a maximal increase above baseline of 248% at 0.1 mM L-NMMA. L-Arginine (1 mM) alone had no significant effect on basal secretion but reversed the potentiating effect of L-NMMA on basal secretion. L-NMMA-induced increases in basal mucus secretion were sustained for at least 30 min in the continuing presence of the NOS inhibitor. In contrast to the potentiating effects of L-NMMA, FK409 (100 nM) reduced basal secretion by 60% (at 1 nM and at 10 nM it was without effect). 3 Electrical stimulation (50 V, 10 Hz, 0.5 ms for 5 min) increased (SO4)-S-35 output by 174%. L-NMMA (1 and 10 mM) present during stimulation of tracheal segments resulted in significant potentiations of 214% and 116%, respectively, of the neurogenic response. The potentiated response to 10 mM L-NMMA was reversed by L-arginine (1 mM). At this dose L-arginine had no effect itself on basal secretion. In contrast to the potentiating effects of L-NMMA on neurogenic secretion, FK409 at 10 nM and 100 nM inhibited the neurogenic response by 98% and 99%. 4 At all concentrations tested, neither L-NMMA (0.01 mM-1 mM) nor FK409 (1-100 mM) had any significant effect on ACh-induced mucus secretion. 5 These observations lead us to conclude that nitric oxide, derived from constitutive NO synthase, acts as an endogenous inhibitor of both basal and neurogenic mucus secretion in ferret trachea in vitro.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 21 条
[1]   HYPERSECRETION OF MUCIN IN RESPONSE TO INFLAMMATORY MEDIATORS BY GUINEA-PIG TRACHEAL EPITHELIAL-CELLS IN-VITRO IS BLOCKED BY INHIBITION OF NITRIC-OXIDE SYNTHASE [J].
ADLER, KB ;
FISCHER, BM ;
LI, HF ;
CHOE, NH ;
WRIGHT, DT .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (05) :526-530
[2]   NERVOUS CONTROL OF MUCIN SECRETION INTO HUMAN BRONCHI [J].
BAKER, B ;
PEATFIELD, AC ;
RICHARDSON, PS .
JOURNAL OF PHYSIOLOGY-LONDON, 1985, 365 (AUG) :297-305
[3]  
BARNES PJ, 1995, PHARMACOL REV, V47, P87
[4]   NITRIC-OXIDE AND LUNG-DISEASE [J].
BARNES, PJ ;
BELVISI, MG .
THORAX, 1993, 48 (10) :1034-1043
[5]  
BELVISI MG, 1995, ARCH INT PHARMACOD T, V329, P97
[6]  
BERNAREGGI M, 1996, IN PRESS BR J PHARM, V117
[7]   CHOLERA-TOXIN AUGMENTS THE RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR EVOKED BY BRADYKININ AND THE CALCIUM IONOPHORE A23187 [J].
BOULANGER, CM ;
VANHOUTTE, PM .
GENERAL PHARMACOLOGY, 1992, 23 (01) :27-31
[8]   NITRIC-OXIDE GENERATORS AND CGMP STIMULATE MUCUS SECRETION BY RAT GASTRIC-MUCOSAL CELLS [J].
BROWN, JF ;
KEATES, AC ;
HANSON, PJ ;
WHITTLE, BJR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :G418-G422
[9]   NITRIC-OXIDE DONORS INCREASE MUCUS GEL THICKNESS IN RAT STOMACH [J].
BROWN, JF ;
HANSON, PJ ;
WHITTLE, BJR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 223 (01) :103-104
[10]   COLOCALIZATION OF VASOACTIVE-INTESTINAL-PEPTIDE AND NITRIC-OXIDE SYNTHASE IN NEURONS OF THE FERRET TRACHEA [J].
DEY, RD ;
MAYER, B ;
SAID, SI .
NEUROSCIENCE, 1993, 54 (04) :839-843